Investigators reviewed 12 years worth of climate data and uveitis prevalence from mainland China to evaluate whether a connection exists.
Researchers say the risk of developing ocular hypertension for patients with mosquito-borne illness is high.
International Workshop Recommendations for Treatment of Uveitis Include Corticosteroid Eye Drops, Systemic Corticosteroids
Investigators compared automated imaging measures of inflammation with clinical exam assessment of activity in uveitis patients to determine efficacy.
Researchers evaluate adeno-associated virus-related immune responses, toxicity and inflammation across various studies on retinal gene therapy.
Tocilizumab may be beneficial for adults with COVID-19 admitted to the ICU, although other findings are conflicting.
IRIS Registry data shows which patients respond to laser trabeculoplasty.
For moderately ill hospitalized patients with COVID-19, tocilizumab is not effective for preventing intubation or death.
Researchers assessed the impact Tocilizumab had on patients with non-infectious uveitis and found that the antibody reduced inflammation in eyes with the disease.
Researchers sought to describe the frequency of ocular flares in patients with non-infectious uveitis who switch from originator infliximab to biosimilar infliximab.
Between one-fifth and one-third of patients with rheumatoid arthritis, connective tissue disease, and vasculitis have ocular complications.
Researchers addressed the genetic association between juvenile idiopathic arthritis-associated uveitis and idiopathic pediatric uveitis.